Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach.

García Layana A, Adán A, Ascaso FJ, Cabrera F, Donate J, Escobar Barranco JJ, Peralta G, Reyes García R, Rodríguez Maqueda M, Ruiz-Moreno JM, Vinagre I; MOMENTUM-D Study Group.

Eur J Ophthalmol. 2019 Jul 10:1120672119861623. doi: 10.1177/1120672119861623. [Epub ahead of print]

PMID:
31291782
2.

First-line treatment algorithm and guidelines in center-involving diabetic macular edema.

Kodjikian L, Bellocq D, Bandello F, Loewenstein A, Chakravarthy U, Koh A, Augustin A, de Smet MD, Chhablani J, Tufail A, García-Layana A, Sudhalkar A, Mathis T.

Eur J Ophthalmol. 2019 Nov;29(6):573-584. doi: 10.1177/1120672119857511. Epub 2019 Jun 26.

PMID:
31238719
3.

In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization.

Luis de Redín I, Boiero C, Recalde S, Agüeros M, Allemandi D, Llabot JM, García-Layana A, Irache JM.

Exp Eye Res. 2019 Aug;185:107697. doi: 10.1016/j.exer.2019.107697. Epub 2019 Jun 19.

PMID:
31228461
4.

Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN).

Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, García-Layana A, Ruiz-Moreno JM.

Prog Retin Eye Res. 2019 Mar;69:80-115. doi: 10.1016/j.preteyeres.2018.10.005. Epub 2018 Nov 1. Review.

5.

Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women.

Fernandez-Robredo P, Recalde S, Hernandez M, Zarranz-Ventura J, Molins B, Casaroli-Marano RP, Adan A, Saenz-de-Viteri M, García-Layana A.

Front Immunol. 2018 Aug 14;9:1862. doi: 10.3389/fimmu.2018.01862. eCollection 2018.

6.

Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants.

García-Layana A, Figueroa MS, Arias L, Adán A, Cabrera F, Abraldes M, Fernández-Vega Á, Navarro R, Cervera E, Silva R, Armadá F, Donate J, Ruiz-Moreno JM.

Ophthalmologica. 2018;240(2):61-72. doi: 10.1159/000486800. Epub 2018 Apr 4. Review. Erratum in: Ophthalmologica. 2018;240(2):72.

PMID:
29617689
7.

Dairy products intake and the risk of incident cataracts surgery in an elderly Mediterranean population: results from the PREDIMED study.

Camacho-Barcia L, Bulló M, García-Gavilán JF, Martínez-González MA, Corella D, Estruch R, Fitó M, Gómez-Gracia E, Arós F, Fiol M, Santos-Lozano JM, Serra-Majem L, Pintó X, Basora J, Toledo E, Muñoz MA, Zanon-Moreno V, García-Layana A, Salas-Salvadó J.

Eur J Nutr. 2019 Mar;58(2):619-627. doi: 10.1007/s00394-018-1647-8. Epub 2018 Mar 27.

PMID:
29589119
8.

Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery.

Garcia-Garcia L, Recalde S, Hernandez M, Bezunartea J, Rodriguez-Madoz JR, Johnen S, Diarra S, Marie C, Izsvák Z, Ivics Z, Scherman D, Kropp M, Thumann G, Prosper F, Fernandez-Robredo P, Garcia-Layana A.

Mol Ther Nucleic Acids. 2017 Dec 15;9:1-11. doi: 10.1016/j.omtn.2017.08.001. Epub 2017 Aug 12.

9.

Early and intermediate age-related macular degeneration: update and clinical review.

García-Layana A, Cabrera-López F, García-Arumí J, Arias-Barquet L, Ruiz-Moreno JM.

Clin Interv Aging. 2017 Oct 3;12:1579-1587. doi: 10.2147/CIA.S142685. eCollection 2017. Review.

10.

Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration.

Cobos E, Recalde S, Anter J, Hernandez-Sanchez M, Barreales C, Olavarrieta L, Valverde A, Suarez-Figueroa M, Cruz F, Abraldes M, Pérez-Pérez J, Fernández-Robredo P, Arias L, García-Layana A.

Acta Ophthalmol. 2018 Mar;96(2):e201-e212. doi: 10.1111/aos.13519. Epub 2017 Sep 19.

11.

Association of Dietary Vitamin K1 Intake With the Incidence of Cataract Surgery in an Adult Mediterranean Population: A Secondary Analysis of a Randomized Clinical Trial.

Camacho-Barcia ML, Bulló M, Garcia-Gavilán JF, Ruiz-Canela M, Corella D, Estruch R, Fitó M, García-Layana A, Arós F, Fiol M, Lapetra J, Serra-Majem L, Pintó X, García-Arellano A, Vinyoles E, Sorli JV, Salas-Salvadó J.

JAMA Ophthalmol. 2017 Jun 1;135(6):657-661. doi: 10.1001/jamaophthalmol.2017.1076.

12.

The Effect of a Mediterranean Diet on the Incidence of Cataract Surgery.

García-Layana A, Ciufo G, Toledo E, Martínez-González MA, Corella D, Fitó M, Estruch R, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Pintó X, Portillo MP, Sorli JV, Bulló M, Vinyoles E, Sala-Vila A, Ros E, Salas-Salvadó J, Arós F.

Nutrients. 2017 May 3;9(5). pii: E453. doi: 10.3390/nu9050453.

13.

Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes.

Velazquez-Villoria A, Recalde S, Anter J, Bezunartea J, Hernandez-Sanchez M, García-García L, Alonso E, Ruiz-Moreno JM, Araiz-Iribarren J, Fernandez-Robredo P, García-Layana A.

PLoS One. 2016 Sep 19;11(9):e0162296. doi: 10.1371/journal.pone.0162296. eCollection 2016.

14.

Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial.

Sala-Vila A, Díaz-López A, Valls-Pedret C, Cofán M, García-Layana A, Lamuela-Raventós RM, Castañer O, Zanon-Moreno V, Martinez-Gonzalez MA, Toledo E, Basora J, Salas-Salvadó J, Corella D, Gómez-Gracia E, Fiol M, Estruch R, Lapetra J, Fitó M, Arós F, Serra-Majem L, Pintó X, Ros E; Prevención con Dieta Mediterránea (PREDIMED) Investigators.

JAMA Ophthalmol. 2016 Oct 1;134(10):1142-1149. doi: 10.1001/jamaophthalmol.2016.2906.

PMID:
27541690
15.

Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions.

Saenz-de-Viteri M, Fernández-Robredo P, Hernández M, Bezunartea J, Reiter N, Recalde S, García-Layana A.

Biochem Pharmacol. 2016 Mar 1;103:129-39. doi: 10.1016/j.bcp.2015.12.017. Epub 2016 Jan 12.

PMID:
26793998
16.

Omega-3 Fatty Acids and Age-Related Macular Degeneration.

Souied EH, Aslam T, Garcia-Layana A, Holz FG, Leys A, Silva R, Delcourt C.

Ophthalmic Res. 2015;55(2):62-9. doi: 10.1159/000441359. Epub 2015 Nov 27. Review.

17.

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration.

García-Layana A, Figueroa MS, Arias L, Araiz J, Ruiz-Moreno JM, García-Arumí J, Gómez-Ulla F, López-Gálvez MI, Cabrera-López F, García-Campos JM, Monés J, Cervera E, Armadá F, Gallego-Pinazo R.

J Ophthalmol. 2015;2015:412903. doi: 10.1155/2015/412903. Epub 2015 Sep 27. Review.

18.

Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept.

García-Layana A, Figueroa MS, Araiz J, Ruiz-Moreno JM, Gómez-Ulla F, Arias-Barquet L, Reiter N.

Drugs Aging. 2015 Oct;32(10):797-807. doi: 10.1007/s40266-015-0300-y. Review.

19.

Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.

Recalde S, Tortajada A, Subias M, Anter J, Blasco M, Maranta R, Coco R, Pinto S, Noris M, García-Layana A, Rodríguez de Córdoba S.

J Am Soc Nephrol. 2016 May;27(5):1305-11. doi: 10.1681/ASN.2015050580. Epub 2015 Sep 16.

20.

Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice.

Ivanescu AA, Fernández-Robredo P, Heras-Mulero H, Sádaba-Echarri LM, García-García L, Fernández-García V, Moreno-Orduna M, Redondo-Exposito A, Recalde S, García-Layana A.

Nutrients. 2015 Jul 6;7(7):5423-42. doi: 10.3390/nu7075229.

21.

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: SIX YEARS OUTCOME.

Ruiz-Moreno JM, Montero JA, Araiz J, Arias L, García-Layana A, Carneiro A, Figueroa MS, Silva R.

Retina. 2015 Dec;35(12):2450-6. doi: 10.1097/IAE.0000000000000632.

PMID:
26049616
22.

Nuevas perspectivas en el tratamiento de enfermedades retinianas con aflibercept.

García Layana A, Donate López J.

Arch Soc Esp Oftalmol. 2015 Mar;90 Suppl 1:1-2. doi: 10.1016/S0365-6691(15)30001-0. Spanish. No abstract available.

PMID:
25925043
23.

A review of current management of vitreomacular traction and macular hole.

García-Layana A, García-Arumí J, Ruiz-Moreno JM, Arias-Barquet L, Cabrera-López F, Figueroa MS.

J Ophthalmol. 2015;2015:809640. doi: 10.1155/2015/809640. Epub 2015 Mar 3. Review.

24.

Current state of therapeutic strategies with ranibizumab in neovascular age-related macular degeneration.

Gallego-Pinazo R, Figueroa MS, García-Layana A.

Curr Opin Ophthalmol. 2015 May;26(3):200-5. doi: 10.1097/ICU.0000000000000151. Review.

PMID:
25774961
25.

A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.

García-Layana A, Arias L, Figueroa MS, Araiz J, Ruiz-Moreno JM, García-Arumí J, Gómez-Ulla F, López-Gálvez MI, Cabrera-López F, García-Campos JM, Monés J, Cervera E, Armadá F, Gallego-Pinazo R, Piñero-Bustamante A, Serrano-Garcia MA.

J Ophthalmol. 2014;2014:595132. doi: 10.1155/2014/595132. Epub 2014 Dec 21.

26.

European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study.

Aslam T, Delcourt C, Holz F, García-Layana A, Leys A, Silva RM, Souied E.

Clin Ophthalmol. 2014 Oct 10;8:2045-53. doi: 10.2147/OPTH.S63937. eCollection 2014.

27.

Evaluation of macular retinal ganglion cell-inner plexiform layer thickness after vitrectomy with internal limiting membrane peeling for idiopathic macular holes.

Sabater AL, Velázquez-Villoria Á, Zapata MA, Figueroa MS, Suárez-Leoz M, Arrevola L, Teijeiro MÁ, García-Layana A.

Biomed Res Int. 2014;2014:458631. doi: 10.1155/2014/458631. Epub 2014 Jul 7.

28.

Oxidative stress and histological changes in a model of retinal phototoxicity in rabbits.

Saenz-de-Viteri M, Heras-Mulero H, Fernández-Robredo P, Recalde S, Hernández M, Reiter N, Moreno-Orduña M, García-Layana A.

Oxid Med Cell Longev. 2014;2014:637137. doi: 10.1155/2014/637137. Epub 2014 May 27.

29.

Age macular degeneration: etiology, prevention, individualized therapies, cell therapy, and tissue engineering.

García-Layana A, Thumann G, Groll J.

J Ophthalmol. 2014;2014:287893. doi: 10.1155/2014/287893. Epub 2014 Mar 23. No abstract available.

30.

Do nutritional supplements have a role in age macular degeneration prevention?

Pinazo-Durán MD, Gómez-Ulla F, Arias L, Araiz J, Casaroli-Marano R, Gallego-Pinazo R, García-Medina JJ, López-Gálvez MI, Manzanas L, Salas A, Zapata M, Diaz-Llopis M, García-Layana A.

J Ophthalmol. 2014;2014:901686. doi: 10.1155/2014/901686. Epub 2014 Jan 23. Review.

31.

Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Fernández-Robredo P, Sancho A, Johnen S, Recalde S, Gama N, Thumann G, Groll J, García-Layana A.

J Ophthalmol. 2014;2014:510285. doi: 10.1155/2014/510285. Epub 2014 Jan 14. Review.

32.

Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Saenz-de-Viteri M, Fernández-Robredo P, de Nova E, Bonet-Farriol E, Sabater AL, Zarranz-Ventura J, Caire J, Sádaba LM, Salinas-Alamán A, García-Layana A.

Int J Ophthalmol. 2013 Dec 18;6(6):801-4. doi: 10.3980/j.issn.2222-3959.2013.06.11. eCollection 2013.

33.

Smoking and age-related macular degeneration: review and update.

Velilla S, García-Medina JJ, García-Layana A, Dolz-Marco R, Pons-Vázquez S, Pinazo-Durán MD, Gómez-Ulla F, Arévalo JF, Díaz-Llopis M, Gallego-Pinazo R.

J Ophthalmol. 2013;2013:895147. doi: 10.1155/2013/895147. Epub 2013 Dec 4. Review.

34.

[Ranibizumab versus bevacizumab. Pharmacological considerations].

Azanza Perea JR, García Layana A.

Arch Soc Esp Oftalmol. 2012 Dec;87 Suppl 1:3-9. doi: 10.1016/S0365-6691(12)70046-1. Review. Spanish.

PMID:
23380435
35.

Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.

Zarranz-Ventura J, Fernández-Robredo P, Recalde S, Salinas-Alamán A, Borrás-Cuesta F, Dotor J, García-Layana A.

PLoS One. 2013 May 31;8(5):e65434. doi: 10.1371/journal.pone.0065434. Print 2013.

36.

Effect of lutein and antioxidant supplementation on VEGF expression, MMP-2 activity, and ultrastructural alterations in apolipoprotein E-deficient mouse.

Fernández-Robredo P, Sádaba LM, Salinas-Alamán A, Recalde S, Rodríguez JA, García-Layana A.

Oxid Med Cell Longev. 2013;2013:213505. doi: 10.1155/2013/213505. Epub 2013 Apr 30.

37.

Massive lipid exudation and retinal detachment after combined brachytherapy and transpupillary thermotherapy in choroidal melanoma.

Zarranz-Ventura J, Salinas-Alamán A, Barrio-Barrio J, de Nova E, Bonet E, García-Layana A.

Arch Soc Esp Oftalmol. 2013 May;88(5):197-200. doi: 10.1016/j.oftal.2012.02.012. Epub 2012 Jun 4. English, Spanish.

PMID:
23623022
38.

Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial.

García-Layana A, Recalde S, Alamán AS, Robredo PF.

Nutrients. 2013 Feb 15;5(2):543-51. doi: 10.3390/nu5020543.

39.

Azithromycin reduces inflammation in a rat model of acute conjunctivitis.

Fernandez-Robredo P, Recalde S, Moreno-Orduña M, García-García L, Zarranz-Ventura J, García-Layana A.

Mol Vis. 2013;19:153-65. Epub 2013 Jan 28.

40.

Micronutrients in age-related macular degeneration.

Aslam T, Delcourt C, Silva R, Holz FG, Leys A, Garcià Layana A, Souied E.

Ophthalmologica. 2013;229(2):75-9. doi: 10.1159/000343708. Epub 2012 Nov 20. Review.

41.

Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.

Martínez-Barricarte R, Recalde S, Fernández-Robredo P, Millán I, Olavarrieta L, Viñuela A, Pérez-Pérez J, García-Layana A, Rodríguez de Córdoba S; Spanish Multicenter Group on AMD.

Invest Ophthalmol Vis Sci. 2012 Mar 1;53(3):1087-94. doi: 10.1167/iovs.11-8709.

42.

Myopic choroidal neovascularization.

Ruiz-Moreno JM, López-Gálvez MI, Donate J, Gomez-Ulla F, García-Arumí J, García-Layana A, Sellés I, Reche J, Montero JA, Pazos B, Zapata MA, Pastor JC.

Ophthalmology. 2011 Dec;118(12):2521-3. doi: 10.1016/j.ophtha.2011.07.029. No abstract available.

PMID:
22136676
43.

Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.

Recalde S, Zarranz-Ventura J, Fernández-Robredo P, García-Gómez PJ, Salinas-Alamán A, Borrás-Cuesta F, Dotor J, García-Layana A.

Invest Ophthalmol Vis Sci. 2011 Sep 9;52(10):7090-7. doi: 10.1167/iovs.11-7300.

PMID:
21810978
44.

[Genetics and ARMD: from the laboratory to the consulting room].

García Layana A, Zarranz-Ventura J, Fernández Robredo P, Recalde S, Rodríguez de Córdoba S; Grupo Español de Investigación Cooperativa en DMAE.

Arch Soc Esp Oftalmol. 2011 Apr;86(4):101-2. doi: 10.1016/j.oftal.2011.03.005. Spanish. No abstract available.

PMID:
21569917
45.

[SERV clinical practice guidelines: management of retinal vein occlusion. Sociedad Española de Retina y Vitreo].

Gómez-Ulla F, Abraldes MJ, Basauri E, Fernández M, García-Layana A, Gili P, Montero J, Nadal J, Morales V, Saravia M, Cabrera F, Cervera E; Sociedad Española de Retina y Vitreo.

Arch Soc Esp Oftalmol. 2010 Sep;85(9):294-309. doi: 10.1016/j.oftal.2010.10.002. Epub 2010 Nov 13. Spanish.

PMID:
21167436
46.

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.

Salinas-Alamán A, Zarranz-Ventura J, Caire González-Jauregui JM, Sádaba-Echarri LM, Barrio-Barrio J, García-Layana A.

Eur J Ophthalmol. 2011 Jul-Aug;21(4):434-9. doi: 10.5301/EJO.2010.6101.

PMID:
21140369
47.

Prevalence and causes of bilateral blindness and visual impairment among institutionalized elderly people in Pamplona, Spain.

Sainz-Gómez C, Fernández-Robredo P, Salinas-Alamán A, Montañés JM, Escudero Berasategui JM, Guillén-Grima F, Ruiz-Moreno JM, García-Layana A.

Eur J Ophthalmol. 2010 Mar-Apr;20(2):442-50.

PMID:
20213621
48.

Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-E deficient mice.

Fernández-Robredo P, Recalde S, Arnáiz G, Salinas-Alamán A, Sádaba LM, Moreno-Orduña M, García-Layana A.

Curr Eye Res. 2009 Jul;34(7):543-52.

PMID:
19899967
49.

Development of laser-induced choroidal neovascularization in rats after retinal damage by sodium iodate injection.

García-Layana A, Vásquez G, Salinas-Alamán A, Moreno-Montañés J, Recalde S, Fernández-Robredo P.

Ophthalmic Res. 2009;42(4):205-12. doi: 10.1159/000232946. Epub 2009 Aug 11.

PMID:
19672129
50.

Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration.

Hernández-Pastor LJ, Ortega A, García-Layana A, Giráldez J.

Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):467-76. doi: 10.1007/s00417-009-1156-9. Epub 2009 Aug 11.

PMID:
19669678

Supplemental Content

Loading ...
Support Center